JP2024535871A5 - - Google Patents
Info
- Publication number
- JP2024535871A5 JP2024535871A5 JP2024517078A JP2024517078A JP2024535871A5 JP 2024535871 A5 JP2024535871 A5 JP 2024535871A5 JP 2024517078 A JP2024517078 A JP 2024517078A JP 2024517078 A JP2024517078 A JP 2024517078A JP 2024535871 A5 JP2024535871 A5 JP 2024535871A5
- Authority
- JP
- Japan
- Prior art keywords
- thc
- pharmaceutical product
- product according
- compound
- rutin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163245799P | 2021-09-17 | 2021-09-17 | |
| US63/245,799 | 2021-09-17 | ||
| PCT/US2022/076579 WO2023044433A1 (en) | 2021-09-17 | 2022-09-16 | Compositions and methods for treating patients with dementia due to alzheimer's disease with a combination of thc and melatonin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535871A JP2024535871A (ja) | 2024-10-02 |
| JP2024535871A5 true JP2024535871A5 (https=) | 2025-09-25 |
Family
ID=83688895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024517078A Pending JP2024535871A (ja) | 2021-09-17 | 2022-09-16 | アルツハイマー病による認知症を有する患者をｔｈｃとメラトニンとの組合せで処置するための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250275935A1 (https=) |
| EP (1) | EP4401717A1 (https=) |
| JP (1) | JP2024535871A (https=) |
| CA (1) | CA3232209A1 (https=) |
| CL (1) | CL2024000782A1 (https=) |
| CO (1) | CO2024004628A2 (https=) |
| PE (1) | PE20241236A1 (https=) |
| WO (1) | WO2023044433A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3773527A4 (en) | 2018-03-30 | 2022-04-13 | India Globalization Capital, Inc. | METHOD AND COMPOSITION FOR THE TREATMENT OF CNS DISEASES |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR44305E (fr) | 1933-12-09 | 1934-12-24 | Meaf Mach En Apparaten Fab Nv | Circuits de voie à rails sans potentiel ou portés au même potentiel |
| US11065225B1 (en) | 2015-07-30 | 2021-07-20 | University Of South Florida | Ultra-low dose THC as a potential therapeutic and prophylactic agent for Alzheimer's disease |
| EP3538122B1 (en) * | 2016-11-14 | 2025-03-26 | Farm To Farma, Inc. | Cannabinoid formulations and method of making the same |
| EP3582755A4 (en) * | 2017-02-15 | 2020-12-23 | Molecular Infusions, LLC | PREPARATIONS |
| WO2019036243A1 (en) * | 2017-08-16 | 2019-02-21 | Molecular Infusions, Llc | Formulations |
| US20200246404A1 (en) * | 2017-02-15 | 2020-08-06 | Molecular Infusions, Llc | Formulations |
| EP3773527A4 (en) | 2018-03-30 | 2022-04-13 | India Globalization Capital, Inc. | METHOD AND COMPOSITION FOR THE TREATMENT OF CNS DISEASES |
| WO2021011421A1 (en) * | 2019-07-12 | 2021-01-21 | University Of South Florida | Compositions and methods for treating alzheimers disease |
-
2022
- 2022-09-16 EP EP22786718.1A patent/EP4401717A1/en active Pending
- 2022-09-16 CA CA3232209A patent/CA3232209A1/en active Pending
- 2022-09-16 US US18/692,705 patent/US20250275935A1/en active Pending
- 2022-09-16 WO PCT/US2022/076579 patent/WO2023044433A1/en not_active Ceased
- 2022-09-16 PE PE2024000480A patent/PE20241236A1/es unknown
- 2022-09-16 JP JP2024517078A patent/JP2024535871A/ja active Pending
-
2024
- 2024-03-15 CL CL2024000782A patent/CL2024000782A1/es unknown
- 2024-04-12 CO CONC2024/0004628A patent/CO2024004628A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210186870A1 (en) | Improved cannabinoid bioavailability | |
| WO2021123804A1 (en) | Oral cannabinoid formulations | |
| US20190134121A1 (en) | Method for reduction, suppression, or elimination of anxiety or marijuana/cannabis effects and related marijuana/cannabis product by process | |
| EP3164141B1 (en) | Food and beverage compositions infused with lipophilic active agents and methods of use thereof | |
| González et al. | Effects of flavonoids and other polyphenols on inflammation | |
| TWI527582B (zh) | 生育三烯酚組合物 | |
| US20230172846A1 (en) | Oral dissolvable film and method of manufacturing and using the same | |
| RU2018107713A (ru) | Композиции на основе флавоноидов и способы применения | |
| US20030105031A1 (en) | Methods for the treatment of skin disorders | |
| MX2007007038A (es) | Formulacion de dronabinol en temperatura ambiente. | |
| CA2454644A1 (en) | Cannabinoid liquid formulations for mucosal administration | |
| JP2009541479A (ja) | 神経因性疼痛の治療用カンナビノイド | |
| JP4411414B2 (ja) | 糖尿病性神経障害の治療に対する組成物及びその方法 | |
| CA3053187A1 (en) | Cannabinoid-containing fatty acid formulations for treating disorders of the nervous system | |
| Hendawy | Nano-Delivery Systems for Improving Therapeutic Efficiency of Dietary Polyphenols. | |
| US20250241980A1 (en) | Topical antibiotic | |
| JP2024535871A5 (https=) | ||
| Zhong et al. | Dietary polyphenols ameliorate inflammatory bowel diseases: advances and future perspectives to maximize their nutraceutical applications | |
| Akkewar et al. | Mangiferin: A natural bioactive immunomodulating glucosylxanthone with potential against cancer and rheumatoid arthritis | |
| EP3826630B1 (en) | Cannabinoids compositions with polyunsaturated fatty acid monoglycerides and use thereof | |
| Sun et al. | Phytonutrients as potential dietary supplements to ameliorate sarcopenia via the involvement of autophagic pathway | |
| JP2001064172A (ja) | Ａｐｃ遺伝子の変異に起因する疾患の予防・治療剤 | |
| JP5551326B2 (ja) | 閉経後の女性および下等動物における脂溶性ビタミンの腸吸収を増進する際の方法 | |
| Prasad et al. | Recent advances in synthetic aspects of naringenin flavonoid and its bioprotective effect (A Review) | |
| WO2023015378A1 (en) | Stabilization of cannabis resin and solid oral cannabinoid formulations |